The data suggest Asterias’ embryonic stem cell-based therapy may improve motor function. – FierceBiotech
Seeking Alpha |
The data suggest Asterias' embryonic stem cell-based therapy may improve motor function.
FierceBiotech Asterias Biotherapeutics has posted data from a phase 1/2a trial of its embryonic stem cell-based therapy. After six months, motor levels of all five evaluable patients who received a 10-million-cell dose have improved. Fremont, California-based … Spinal cord injury patients continue to improve following treatment with Asterias Bio's AST-OPC1 cells; shares ahead … |
